medigraphic.com

2024, Number 1

<< Back Next >>

Rev Mex Anest 2024; 47 (1)

Assessment of COVID-19 symptoms in hospitalized patients through the ESAS-r(es) questionnaire

Cruz-Nocelo EJ, Cerón-Paz I, Barajas-Victoria RÁ, Trejo-Villanueva HA, Zúñiga-Carmona VH, Torres-Prado DE

Language: Spanish
References: 14
Page: 17-22
PDF size: 257.41 Kb.


ABSTRACT

Introduction: COVID-19 is accompanied by symptoms that are usually more evident when the disease is severe. Objective: to evaluate the symptoms of patients hospitalized for COVID-19 through the ESAS-r(es) questionnaire and compare their intensity according to severity. Material and methods: a cross-sectional, prospective and observational study was carried out, which consisted of the evaluation of the intensity of symptoms in hospitalized patients with COVID-19 and was compared according to severity. Results: 110 evaluations were included, most of the symptoms presented with greater intensity in the severe severity group: exhaustion (p ≤ 0.001), loss of appetite (p = 0.006), shortness of breath (p = 0.001), discouragement (p = 0.009) and nervousness/anxiety (p = 0.041). Conclusion: the symptoms occurred with greater frequency and intensity in severe disease.


REFERENCES

  1. Secretaría de Gobernación [SEGOB]. Acuerdo por el que el Consejo de Salubridad General declara la obligatoriedad de los esquemas de manejo integral de cuidados paliativos, así como los procesos señalados de la guía del manejo integral de cuidados paliativos [Internet]. 2014 [consultado el 9 ene 2023]. Disponible en: http://www.dof.gob.mx/nota_detalle.php?codigo=5377407&fecha=26/12/2014

  2. Secretaría de Gobernación [SEGOB]. Acuerdo que modifica el Anexo Único del diverso por el que el Consejo de Salubridad General declara la obligatoriedad de los Esquemas de Manejo Integral de Cuidados Paliativos, así como los procesos señalados en la Guía del Manejo Integral de Cuidados Paliativos, publicado el 26 de diciembre de 2014 [Internet]. 2018 [Consultado el 9 ene 2023]. Disponible en: https://www.dof.gob.mx/nota_detalle.php?codigo=5534718&fecha=14/08/2018

  3. World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization. 2020 [accessed January 25, 2022]. Available in: https://iris.who.int/handle/10665/332196

  4. Lovell N, Maddocks M, Etkind SN, Taylor K, Carey I, Vora V, et al. Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care. J Pain Symptom Manage. 2020;60:e77-e81. doi: 10.1016/j.jpainsymman.2020.04.015.

  5. Fusi-Schmidhauser T, Preston NJ, Keller N, Gamondi C. Conservative management of COVID-19 patients-emergency palliative care in action. J Pain Symptom Manage. 2020;60:e27-e30. doi: 10.1016/j.jpainsymman.2020.03.030

  6. Carvajal VA, Martínez GM, Centeno CC. Versión española del Edmonton Symptom Assessment System (ESAS): un instrumento de referencia para la valoración sintomática del paciente con cáncer avanzado. Med Paliat. 2013;20:143-149.

  7. Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med. 2020;46:357-360. doi: 10.1007/s00134-020-05954-2.

  8. Sahin T, Ayyildiz A, Gencer-Atalay K, Akgün C, Ozdemir HM, Kuran B. Pain symptoms in COVID-19. Am J Phys Med Rehabil. 2021;100:307-312. doi: 10.1097/PHM.0000000000001699.

  9. Beng TS, Kim CLC, Shee CC, Ching DNL, Liang TJ, Kumar MKN, et al. COVID-19, suffering and palliative care: a review. Am J Hosp Palliat Care. 2021;16:10499091211046233. doi: 10.1177/10499091211046233.

  10. Iglesias-González M, Boigues M, Sanagustin D, Giralt-López M, Cuevas-Esteban J, Martínez-Cáceres E, et al. Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients. Brain Behav Immun Health. 2022;19:100405. doi: 10.1016/j.bbih.2021.100405.

  11. Keeley P, Buchanan D, Carolan C, Pivodic L, Tavabie S, Noble S. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary. BMJ Support Palliat Care. 2020;10:381-384. doi: 10.1136/bmjspcare-2020-002368.

  12. Hetherington L, Johnston B, Kotronoulas G, Finlay F, Keeley P, McKeown A. COVID-19 and Hospital Palliative Care - A service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist Hospital Palliative Care. Palliat Med. 2020;34:1256-1262. doi: 10.1177/0269216320949786.

  13. Wong A, Keith C, Gregory H, Liew D. Palliative and supportive care prescribing considerations around qt prolongation risk in the context of COVID-19 (coronavirus disease 2019) management. J Pain Palliat Care Pharmacother. 2020;34:237-239. doi: 10.1080/15360288.2020.1814481.

  14. Andreas M, Piechotta V, Skoetz N, Grummich K, Becker M, Joos L, et al. Interventions for palliative symptom control in COVID-19 patients. Cochrane Database Syst Rev. 2021;8:CD015061. doi: 10.1002/14651858.CD015061.




2020     |     www.medigraphic.com